Skip to main content

Table 2 Incremental cost-effectiveness ratio of an abdominal aortic aneurysm screening strategy compared with no screening

From: Cost-effectiveness of a population-based AAA screening program for men over 65 years old in Iran

Strategy

Average

Incremental

ICER

Cost (US$)

QALY

LYG

Cost (US$)

QALY

LYG

Cost (US$) per QALY

Cost (US$) per LYG

No screening

267

8.780

10.890

–

–

–

–

–

Screening

407

8.806

10.924

140

0.025

0.034

5566

4106

  1. QALY quality-adjusted life-year, LYG life-years gained, ICER incremental cost-effectiveness ratio